Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $831.9650 (0.68%) ($831.9650 - $831.9650) on Fri. Sep. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.73% (three month average) | RSI | 64 | Latest Price | $831.9650(0.68%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(66%) IBB(61%) DIA(55%) XLF(54%) SDY(51%) | Factors Impacting REGN price | REGN will decline at least -0.865% in a week (0% probabilities). VXX(-45%) VIXM(-41%) TBT(-20%) USO(-18%) UUP(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.865% (StdDev 1.73%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $830.7(0.15%) | 10 Day Moving Average | $833.92(-0.23%) | 20 Day Moving Average | $816.38(1.91%) | To recent high | -1.5% | To recent low | 20.2% | Market Cap | $88.212b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |